Adelaide Oncology & Haematology

What Adelaide Oncology & Haematology does

Adelaide Oncology & Haematology (AOAH) is a private, specialised cancer care provider headquartered in North Adelaide, South Australia, operating as an integrated unit within the GenesisCare network. Founded in 2008 and comprising 11–50 employees, AOAH delivers fully integrated cancer care across three pillars: Medical Oncology (chemotherapy, hormone therapy, immunotherapy, targeted therapies), Haematology (blood cancer diagnosis and treatment), and Radiation Oncology (external beam RT, brachytherapy, Gamma Knife RT, MR Linac, and SABR for prostate cancer). The underlying platform combines these modalities with advanced imaging-guided treatment technology (MR Linac, Theranostics), Telehealth services, access to global clinical trial networks, and the RESTORE supportive care program. AOAH also operates an additional site at Elizabeth Vale (Playford Health Hub) and is described as part of the largest private cancer care provider in South Australia, with GenesisCare having delivered cancer care in the state for over 40 years.

Revenue is generated through professional-services billing for clinical treatments, funded primarily via Australian Medicare rebates, private health insurance, and self-pay arrangements. Pricing is not publicly disclosed and follows a quote-based, pay-as-you-go model with patient enquiries directed to dedicated contact lines for Medical Oncology/Haematology and Radiation Oncology. The go-to-market motion is sales-led and referral-driven: patients are acquired through GP and specialist referral pathways, direct patient enquiries (phone and online forms), and hospital partnerships, with marketing executed largely through the parent GenesisCare digital infrastructure including its website, wellbeing blog, and social channels. The primary customer segment is cancer patients across more than a dozen tumour types (blood, bone, breast, gastrointestinal, genitourinary, gynaecological, head and neck, lung, prostate, skin, spine), with no enterprise or B2B customers disclosed.

The strategic significance of AOAH is best understood as a regional specialty clinical asset within the broader GenesisCare Australia footprint (NSW, QLD, VIC, SA, WA). The integration of AOAH into GenesisCare's South Australian operations consolidated medical oncology, haematology, and radiation oncology under a single coordinated, multidisciplinary pathway — a structure that differentiates AOAH from fragmented single-modality competitors and underpins the claim of being the largest private integrated cancer care provider in the state.

Name

Adelaide Oncology & Haematology

Legal name

Adelaide Oncology & Haematology

Website

https://aoah.com.au

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Adelaide Oncology & Haematology is a private cancer care provider in South Australia, integrated within the GenesisCare network, delivering multidisciplinary medical oncology, haematology, and radiation oncology services to cancer patients across the Adelaide metropolitan area.

Ownership category

akta.pro rank

Product category

Oncology and Haematology Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Oncology services
• Haematology services
• Radiation therapy
• Cancer treatment
• Medical oncology

Headquarters

HQ city

North Adelaide

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Oncology Services: Revenue generated from chemotherapy, hormone therapy, immunotherapy, and targeted therapy treatments for cancer patients
2. Haematology Services: Specialist haematology diagnostic and treatment services for blood cancer and related conditions
3. Radiation Oncology Services: Radiation therapy treatments including external beam RT, brachytherapy, Gamma knife RT, MR Linac, and SABR for prostate cancer

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Adelaide Oncology & Haematology provides integrated cancer care services combining medical oncology, haematology, and radiation oncology delivered through specialist clinical teams at facilities in North Adelaide and Elizabeth Vale. The offering includes chemotherapy, immunotherapy, hormone therapy, targeted therapy, blood cancer diagnosis and treatment, advanced radiation modalities (MR Linac, Gamma Knife, SABR, Brachytherapy, External Beam RT), Theranostics, telehealth consultations, access to clinical trials, and supportive care via the RESTORE Wellness Program.

Product overview

Adelaide Oncology & Haematology (AOAH) is a specialised cancer care service that joined the GenesisCare network, becoming the largest private provider of integrated cancer care in South Australia. The offering operates as a unified platform of coordinated services, combining Medical Oncology, Radiation Oncology, and Haematology as the core pillars, supported by advanced treatment technologies (MR Linac, Gamma Knife, SABR, Brachytherapy, Theranostics), Telehealth Services, Clinical Trials access, and the RESTORE Wellness Program. These services work together to provide multidisciplinary, patient-centred cancer care with streamlined access to integrated services and coordinated care pathways.

Differentiator

Problem solved

Functional benefit

Brands

• RESTORE wellness program: Supportive care services including education, wellbeing support and complementary therapies to help patients throughout treatment and recovery.

Products and services

• Medical Oncology Comprehensive medical oncology treatments including chemotherapy, hormone therapy, immunotherapy, and targeted therapies administered by specialist oncologists for cancer patients across multiple tumour types.
• Radiation Oncology Advanced radiation therapy treatments including External Beam RT, Brachytherapy, Gamma Knife RT, MR Linac, and SABR for prostate cancer, delivered as part of an integrated cancer care service for cancer patients.
• Haematology Specialist haematology services for blood cancer diagnosis and treatment, integrated within the broader GenesisCare cancer care network for patients with blood cancer and related conditions.
• Theranostics Advanced Theranostics treatment service combining diagnostic imaging with targeted therapy for personalised cancer treatment.
• Telehealth Services Remote oncology consultations and follow-up care delivered via secure video conferencing, enabling patients to access specialist care from home.
• Clinical Trials Access to clinical research trials and experimental treatments through GenesisCare's global research partnerships, providing eligible cancer patients with cutting-edge treatment options close to home.
• RESTORE Wellness Program Supportive care program providing education, wellbeing support, and complementary therapies to help cancer patients throughout treatment and recovery.
• MR Linac Radiation Therapy MRI-guided linear accelerator technology combining real-time imaging with radiation delivery for precise tumour targeting in cancer patients.
• Gamma Knife Radiation Therapy Stereotactic radiosurgery using precisely targeted gamma radiation for treatment of brain tumours and neurological conditions in cancer patients.
• SABR for Prostate Cancer Stereotactic ablative radiotherapy (SABR) offering non-invasive, high-dose radiation treatment for prostate cancer patients with fewer sessions than conventional radiotherapy.
• Brachytherapy Internal radiation therapy placing radioactive sources directly within or near the tumour for targeted treatment delivery to cancer patients.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• GenesisCarecoreStrategic or Co-development PartnerAOAH has been integrated into the GenesisCare network, becoming part of the largest private cancer care provider in South Australia. This integration enables AOAH to offer fully integrated cancer care services combining medical oncology, haematology, and radiation oncology under a coordinated, patient-focused care pathway. Patients retain their existing care team while gaining access to expanded services and integrated care pathways across the GenesisCare network.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/adelaide-oncology-haematology
• Instagraminstagram.com/genesiscareau

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adelaide Oncology & Haematology